| Turchia | Austria | Spagna | |
| Chemioterapia Intraperitoneale Ipertermica (HIPEC) | da $22,500 | da $40,000 | da $25,000 |
Il medico ha una vasta esperienza nel campo dell'oncologia peritoneale, attualmente lavora presso il Dipartimento di Carcinomatosi Peritoneale al Centro Médico Teknon in Spagna dal 2020 e presso il Dipartimento di Oncologia Peritoneale al Consorci Sanitari Integral dal 2010. In precedenza, il medico ha lavorato in chirurgia laparoscopica e robotica avanzata, nonché in chirurgia epatobiliare e pancreatica in vari ospedali prestigiosi in Spagna e Italia.<\/p>
Come esperto riconosciuto, il medico interviene frequentemente a congressi nazionali e internazionali sul trattamento chirurgico dei tumori addominali e pelvici avanzati e ha contribuito in modo significativo alla letteratura scientifica e agli studi clinici in chirurgia oncologica.<\/p>
Il medico è membro di diverse società chirurgiche e oncologiche stimate, tra cui GECOP, SEOQ, AEC, ESSO e PSOGI.<\/p>
Dr. Carlos Vergés Roger is a prize-winning ophthalmologist at Dexeus University Hospital in Barcelona. He won the National Research Prize for his groundbreaking study on tear secretion. This work became the foundation for modern dry eye syndrome treatment. Dr. Vergés Roger holds a PhD from Harvard University.
La dottoressa è un chirurgo oncologico specializzato in carcinosi peritoneale e fa parte del Gruppo Chirurgico di Carcinosi dell'Istituto Oncologico Teknon dal 2019. Ha completato la sua specializzazione al Washington Hospital Center sotto la guida del Prof. Paul Sugarbaker e possiede la certificazione dell'American Board of Surgery.<\/p>
È membro di diverse società prestigiose, tra cui l'American College of Surgeons e la Society of Surgical Oncology. I suoi ruoli accademici hanno incluso il Direttore della Ricerca presso l'Inova Fairfax Hospital e posizioni di Professore Associato presso la Virginia Commonwealth University e la Georgetown University.<\/p>
Il medico è un oncologo pediatrico con 37 anni di esperienza, specializzato nel trattamento dei disturbi del sangue e nell'esecuzione di procedure come i trapianti di midollo osseo e la terapia ablativa. Attualmente, il medico è Capo dell'Emato-Oncologia Pediatrica presso l'Ospedale Universitario Quironsalud Madrid.<\/p>
Con un prolifico curriculum accademico, il medico ha curato 14 libri, contribuito a 75 capitoli di libri e presentato a oltre 200 conferenze. Il medico è membro di diverse associazioni professionali, tra cui l'Associazione Spagnola di Ematologia Pediatrica e l'Associazione Spagnola di Oncologia Pediatrica.<\/p>
Il medico tratta un'ampia gamma di condizioni, tra cui leucemia, linfoma, mieloma multiplo e vari disturbi ematologici e autoimmuni.<\/p>
Hyperthermic intraperitoneal chemotherapy (HIPEC) is a concentrated, heated chemotherapy treatment delivered directly into the abdominal cavity during surgery. It targets microscopic cancer cells remaining after a surgeon removes all visible tumors, significantly improving survival rates for advanced abdominal cancers like colorectal and ovarian malignancies.
Bookimed Expert Insight: Spain offers unique access to pioneers like Dr. Lana Bijelic at Centro Médico Teknon. She trained under Dr. Paul Sugarbaker, the father of the HIPEC procedure. Spanish centers often combine HIPEC with PIPAC (pressurized aerosol chemotherapy), providing more options for patients who may not tolerate traditional major surgery.
Patient Consensus: While patients report this procedure can be physically brutal with intense nausea, many view it as a life-extending standard for stage 4 cancer. Success stories include survivors reaching the 9-year mark after treatment.
HIPEC success in Spain shows a median overall survival reaching 47 months in high-volume centers. Specialized institutions achieve complete cytoreduction in over 90% of cases. Outcomes depend on the Peritoneal Cancer Index, with best results observed when scores remain low, typically under 7.
Bookimed Expert Insight: Success in Spain is linked to doctors trained directly by pioneers like Dr. Paul Sugarbaker. Dr. Lana Bijelic at Centro Médico Teknon has performed over 1,300 complex cancer surgeries. This high volume directly correlates with the 90% complete cytoreduction rates seen in top Spanish hospitals.
Patient Consensus: Patients emphasize that success is highly individual and depends more on fitness than statistics. While recurrence is common, around 20% of patients achieve long-term survival lasting up to 9 years.
Hyperthermic intraperitoneal chemotherapy treats advanced cancers that have spread to the abdominal lining, specifically peritoneal carcinomatosis. This intensive therapy targets malignancies including ovarian, colorectal, gastric, and appendix cancers, alongside peritoneal mesothelioma and pseudomyxoma peritonei, by delivering heated drugs directly into the abdominal cavity after surgical tumor removal.
Bookimed Expert Insight: Spanish oncology centers often provide PIPAC alongside traditional HIPEC, offering a less invasive aerosolized alternative for patients with high-volume ascites. Dr. Alfonso García Fadrique at Hospital Vithas Valencia Turia leads specialized R&D into HIPEC quality standards, which is a critical differentiator when choosing a center for such complex 12-hour surgeries.
Patient Consensus: Patients often view this procedure as a decisive first-line attack rather than a last resort. Many emphasize that while the 2-month recovery is demanding, the potential for remaining disease-free for several years makes the intensive surgery worthwhile.
Top hospitals for HIPEC in Spain include Centro Médico Teknon in Barcelona and Hospital Ruber Internacional in Madrid. These JCI-accredited facilities specialize in cytoreductive surgery combined with heated chemotherapy. They feature surgeons trained by global pioneers to treat peritoneal carcinomatosis, pseudomyxoma peritonei, and advanced abdominal cancers.
Bookimed Expert Insight: Data shows a significant experience gap in peritoneal oncology across Europe. At Centro Médico Teknon, Dr. Lana Bijelic has performed over 1,300 complex cancer surgeries. Choosing a surgeon with this specific volume is critical because HIPEC success depends heavily on the thoroughness of the initial debulking surgery.
Patient Consensus: Patients emphasize requesting a Peritoneal Carcinomatosis Index (PCI) score before surgery. They suggest preparing for a 2-week hospital stay and rigorous post-operative monitoring for bowel function recovery.
HIPEC packages in Spain include essential clinical aftercare such as intensive care unit monitoring and specialized post-operative hospital stays. Treatment plans generally cover pre-operative imaging, cytoreductive surgery, and 7 to 10 days of inpatient stabilization to manage pain, nutrition, and digestive healing.
Bookimed Expert Insight: Quality aftercare in Spain is driven by high-volume surgical expertise. Dr. Lana Bijelic at Centro Médico Teknon has performed over 1,300 complex cancer surgeries, having trained under the pioneer of HIPEC. This level of specialization ensures that post-surgical protocols in Barcelona clinics are modeled after the world’s most successful peritoneal surface oncology programs.
Patient Consensus: Patients emphasize managing long-term recovery at home, noting that while hospital care is comprehensive, full normalization can take many months. Using low-fiber diets and staying extremely hydrated during the first few weeks after discharge are common practical recommendations.
The HIPEC procedure typically takes 90 minutes for the heated chemotherapy administration alone. However, when combined with cytoreductive surgery to remove visible tumors, the total operating time usually ranges from 9 to 14 hours in accredited Spanish oncology centers like Centro Médico Teknon.
Bookimed Expert Insight: Data shows that surgical efficiency improves significantly during secondary procedures for recurrence. While initial surgeries often exceed 14 hours, follow-up procedures typically average 8 to 9.5 hours. Choosing a specialist like Dr. Lana Bijelic at Centro Médico Teknon, who has performed over 1,300 procedures, ensures expertise in managing these complex, high-volume timelines.
Patient Consensus: Patients emphasize that the physical toll is high, requiring 7 to 14 days of hospitalization. Most realize that full energy levels only return around 8 months after the procedure.
Recovery after HIPEC in Spain typically requires 3 to 6 months for returning to daily activities and up to 12 months for full functional restoration. This major procedure involves a 7 to 14-day hospital stay including intensive care monitoring and specialized oncology nursing.
Bookimed Expert Insight: While many assume the 90-minute heated chemotherapy causes the long recovery, the preceding cytoreductive surgery actually drives the timeline. Surgeons like Dr. Lana Bijelic at Centro Médico Teknon, who has performed 1,300+ complex cases, emphasize that recovery depends on the extent of organ resection rather than the chemo bath itself.
Patient Consensus: Many describe the first month as physically demanding due to intense fatigue. Practical advice from others highlights the necessity of small, frequent meals and early physiotherapy to safely strengthen the core after abdominal surgery.